DRD2: Bridging the Genome and Ingestive Behavior

Trends Cogn Sci. 2017 May;21(5):372-384. doi: 10.1016/j.tics.2017.03.004. Epub 2017 Mar 31.

Abstract

Recent work highlights the importance of genetic variants that influence brain structure and function in conferring risk for polygenic obesity. The neurotransmitter dopamine (DA) has a pivotal role in energy balance by integrating metabolic signals with circuits supporting cognitive, perceptual, and appetitive functions that guide feeding. It has also been established that diet and obesity alter DA signaling, leading to compulsive-like feeding and neurocognitive impairments. This raises the possibility that genetic variants that influence DA signaling and adaptation confer risk for overeating and cognitive decline. Here, we consider the role of two common gene variants, FTO and TaqIA rs1800497 in driving gene × environment interactions promoting obesity, metabolic dysfunction, and cognitive change via their influence on DA receptor subtype 2 (DRD2) signaling.

Keywords: ANKK1; cognition; diet; dopamine; genetics; inflammation; ingestive behavior; obesity.

Publication types

  • Review

MeSH terms

  • Alpha-Ketoglutarate-Dependent Dioxygenase FTO / genetics*
  • Dopamine
  • Gene-Environment Interaction*
  • Genetic Predisposition to Disease
  • Humans
  • Obesity / genetics*
  • Protein Serine-Threonine Kinases / genetics*
  • Receptors, Dopamine D2 / genetics*

Substances

  • DRD2 protein, human
  • Receptors, Dopamine D2
  • Alpha-Ketoglutarate-Dependent Dioxygenase FTO
  • FTO protein, human
  • Protein Serine-Threonine Kinases
  • Dopamine